Allarity Therapeutics Inc (ALLR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,515 | -17,062 | -5,472 | -3,843 | -11,901 |
| Depreciation Amortization | 9,712 | 9,711 | 3 | 2 | 37 |
| Income taxes - deferred | -446 | -446 | N/A | -14 | 97 |
| Accounts payable and accrued liabilities | -4,108 | -3,623 | -573 | 2,838 | 2,165 |
| Other Working Capital | 63 | -3,843 | -687 | 2,887 | 3,352 |
| Other Operating Activity | 1,942 | 1,117 | -1,974 | -3,269 | -6,495 |
| Operating Cash Flow | $-17,352 | $-14,146 | $-8,703 | $-1,399 | $-12,745 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -298 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-298 | $N/A | $0 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,340 | 4,278 | 1,340 | 1,340 | 1,050 |
| Debt Repayment | -1,340 | -1,340 | -1,340 | N/A | -3,699 |
| Common Stock Issued | 37,354 | 33,119 | 27,689 | 40 | 16,895 |
| Other Financing Activity | -562 | -3,500 | 0 | 0 | -3,251 |
| Financing Cash Flow | $36,792 | $32,557 | $27,689 | $1,380 | $10,995 |
| Exchange Rate Effect | 225 | -114 | 81 | 165 | -113 |
| Beginning Cash Position | 166 | 166 | 166 | 166 | 2,029 |
| End Cash Position | 19,533 | 18,463 | 19,233 | 312 | 166 |
| Net Cash Flow | $19,367 | $18,297 | $19,067 | $146 | $-1,863 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,352 | -14,146 | -8,703 | -1,399 | -12,745 |
| Capital Expenditure | -298 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -17,650 | -14,146 | -8,703 | -1,399 | -12,745 |